UNIVEC, Inc. (OTCMKTS:UNVC) Is A Low Float Runner

Today, we need to assess a new profile that has been pushed up by the market after the release of a new partnership agreement. UNIVEC, Inc. (OTCMKTS:UNVC) is a provider of specialty pharmaceuticals focusing on medical marijuana treatments. Cannabidiol FormulaUNVC has gone from $0.0001 to hit $0.0015 in less than a week. On some days more than 100 million shares changed hands.Have a look at it before we provide more details: Two months chart for UNVCBusinessIn the last report received by the market, the following was explained about the business of UNVC and its subsidiaries:

"Univec, Inc. (Company) distributes, produces, licenses and markets specialty pharmaceutical drugs. Physician and Pharmaceutical Services, Inc. (PPSI), a subsidiary, provides pharmaceutical samples and group purchasing services for pharmaceutical companies and health care providers." Source

According to the profile data given to the OTC Markets, the business entity is quite old. It was incorporated in 1996. In the same document, we could read a little about the state of the business. The document reads as follows:

"The company has gone through a transition period for its business model to focus on pharmaceuticals and the marketing and distribution of its own private line as well as a private distributor of other lines. The Company management believes that the concentrated resources will produce greater results, with greater profit margins." Source

Additionally, it was noted that the company will increase its revenue by placing increased product sales in the direct marketplace and by directing resources on its higher gross profit product sales.How is the company intending to increase its product sales?It has entered into the marijuana medical sector. Regarding the subsidiary, we found more information that pleased us:

"Physician and Pharmaceutical Services, Inc. (PPSI) is a Group Purchasing Organization (GPO), formulary management and sampling of pharmaceutical products company. Group purchasing allows companies to get better prices by combining purchasing power. It is also important that the products being purchased are appropriate for the drug formulary that is approved." Source

Recent DevelopmentsThe most interesting news was received on October 2, 2017. It noted that AGRiMED, which owns one of the twelve licenses authorized by the Commonwealth of Pennsylvania to produce marijuana, had signed an agreement with the company. Both companies agreed to manufacture and distribute the cannabis transdermal patch that UNVC designed.According to the press release, this patch delivers a dose of medication through the skin and into the bloodstream. For those who don't know how a patch works, this is the product designed by other healthcare companies:

Transdermal Patch Source: https://www.thegreenchef.ca/wp-content/uploads/2016/01/transdermal-patch.jpg

We were happy to read what Dr. David Dalton, CEO of the company, said in the press release. We agree with his vision:

"Combining Univec's medical and pharmaceutical expertise with AGRiMED Industries' innovative approach to the cannabis marketplace and commitment to its patient focused services makes for a very powerful partnership to expand the treatment options available to the medical community." Source

Share Statistics The following information will be appreciated by our readers. It comes from the OTC Markets website:

• Authorized Shares: 5,005,000,000
• Outstanding Shares: 438,841,704
• Float: 221,867,522
• Par Value: 0.01

What did we see?The float, which is the amount of shares owned by the public, is quite small. This means that UNVC can become a low float runner rather quickly.ConclusionCurrently trading with a market cap of $0.6 million, UNVC is an interesting story among small caps.We see two catalysts. First of all, if the company commences to communicate more as it has done in October and publishes its financial statements, the market may push up the share price. Additionally, if new developments in the marijuana sector are released, we believe that the market will celebrate it as well. To sum up, we like what we see with UNVC and the stock is finally moving in the right direction!We will be updating our subscribers as soon as we know more. For the latest updates on UNVC, sign up below!Image courtesy of Stuart Grout via FlickrDisclosure: We have no position in UNVC and have not been compensated for this article.